Literature DB >> 19218483

IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo.

Young H Kim1, Beom K Choi, Woo J Kang, Kwang H Kim, Sang W Kang, Andrew L Mellor, David H Munn, Byoung S Kwon.   

Abstract

It has been reported that 4-1BB triggering in vivo selectively suppressed the recall response of staphylococcal enterotoxin A (SEA)-specific CD4(+) T cells, in which CD8(+) T-derived TGF-beta was involved. Here, we have examined an alternative mechanism for the 4-1BB-mediated CD4(+) T suppression, as the neutralization of TGF-beta is only effective in rescuing the SEA-specific recall response at high cellular concentrations. We show that this selective suppression of CD4(+) T cells by 4-1BB triggering in vivo is mediated mainly by induction of indoleamine 2,3-dioxygenase (IDO) in an IFN-gamma-dependent manner. SEA-specific CD4(+) T responses were suppressed partly by TGF-beta-expressing CD8(+) T cells, particularly CD11c(+)CD8(+) T cells, but strongly inhibited by dendritic cells (DCs) expressing IDO. IFN-gamma that increased IDO in DCs was produced primarily from CD11c(+)CD8(+) T cells, which were expanded selectively by 4-1BB stimulation. CD4(+), CD8(+), and plasmacytoid DCs exerted a similar suppressive activity toward the SEA-specific CD4(+) T cells. Neutralization of IFN-gamma or IDO activity in vivo largely reversed the 4-1BB-mediated CD4(+) T suppression. Collectively, these data indicate that 4-1BB-dependent suppression of SEA-specific CD4(+) T responses was mediated mainly by IFN-gamma-dependent IDO induction and partially by TGF-beta.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218483      PMCID: PMC2669405          DOI: 10.1189/jlb.0408246

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  46 in total

1.  Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering.

Authors:  Lara Myers; Chikara Takahashi; Robert S Mittler; Robert J Rossi; Anthony T Vella
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-14       Impact factor: 11.205

2.  4-1BB-mediated immunotherapy of rheumatoid arthritis.

Authors:  Su K Seo; Jae H Choi; Young H Kim; Woo J Kang; Hye Y Park; Jae H Suh; Beom K Choi; Dass S Vinay; Byoung S Kwon
Journal:  Nat Med       Date:  2004-09-26       Impact factor: 53.440

3.  Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification.

Authors:  J R Dasch; D R Pace; W Waegell; D Inenaga; L Ellingsworth
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

4.  Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

Authors:  David H Munn; Madhav D Sharma; Deyan Hou; Babak Baban; Jeffrey R Lee; Scott J Antonia; Jane L Messina; Phillip Chandler; Pandelakis A Koni; Andrew L Mellor
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

5.  Inhibition of experimental asthma by indoleamine 2,3-dioxygenase.

Authors:  Tomoko Hayashi; Lucinda Beck; Cyprian Rossetto; Xing Gong; Osamu Takikawa; Kenji Takabayashi; David H Broide; Dennis A Carson; Eyal Raz
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

6.  4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function.

Authors:  Seung-Joo Lee; Lara Myers; Guruprasaadh Muralimohan; Jie Dai; Yi Qiao; Zihai Li; Robert S Mittler; Anthony T Vella
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

7.  Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance.

Authors:  Juergen L Foell; Belkis I Diez-Mendiondo; Oliver H Diez; Ursula Holzer; Peter Ruck; Abhijit S Bapat; Michael K Hoffmann; Robert S Mittler; Guenther E Dannecker
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

8.  Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo.

Authors:  Wojciech Dawicki; Tania H Watts
Journal:  Eur J Immunol       Date:  2004-03       Impact factor: 5.532

9.  NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.

Authors:  Dongping Xu; Peidi Gu; Ping-Ying Pan; Qingsheng Li; Alice I Sato; Shu-Hsia Chen
Journal:  Int J Cancer       Date:  2004-04-20       Impact factor: 7.396

10.  Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy.

Authors:  Ursula Grohmann; Claudia Volpi; Francesca Fallarino; Silvia Bozza; Roberta Bianchi; Carmine Vacca; Ciriana Orabona; Maria L Belladonna; Emira Ayroldi; Giuseppe Nocentini; Louis Boon; Francesco Bistoni; Maria C Fioretti; Luigina Romani; Carlo Riccardi; Paolo Puccetti
Journal:  Nat Med       Date:  2007-04-08       Impact factor: 53.440

View more
  7 in total

1.  IFN-γ-driven IDO production from macrophages protects IL-4Rα-deficient mice against lethality during Schistosoma mansoni infection.

Authors:  Reena Rani; Michael B Jordan; Senad Divanovic; De'Broski R Herbert
Journal:  Am J Pathol       Date:  2012-03-16       Impact factor: 4.307

2.  Central role of IFNgamma-indoleamine 2,3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity.

Authors:  Tao Gu; Rachael B Rowswell-Turner; Mehmet O Kilinc; Nejat K Egilmez
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

3.  The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.

Authors:  D S Vinay; B S Kwon
Journal:  Clin Exp Immunol       Date:  2011-03-14       Impact factor: 4.330

4.  Role of 4-1BB receptor in the control played by CD8(+) T cells on IFN-gamma production by Mycobacterium tuberculosis antigen-specific CD4(+) T Cells.

Authors:  Carla Palma; Silvia Vendetti; Antonio Cassone
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

Review 5.  4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity.

Authors:  Todd Bartkowiak; Michael A Curran
Journal:  Front Oncol       Date:  2015-06-08       Impact factor: 6.244

6.  Cx3cr1 deficiency in mice attenuates hepatic granuloma formation during acute schistosomiasis by enhancing the M2-type polarization of macrophages.

Authors:  Lin Ran; Qilin Yu; Shu Zhang; Fei Xiong; Jia Cheng; Ping Yang; Jun-Fa Xu; Hao Nie; Qin Zhong; Xueli Yang; Fei Yang; Quan Gong; Michal Kuczma; Piotr Kraj; Weikuan Gu; Bo-Xu Ren; Cong-Yi Wang
Journal:  Dis Model Mech       Date:  2015-04-21       Impact factor: 5.758

Review 7.  The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus.

Authors:  Anselm Mak; Herbert Schwarz
Journal:  Cells       Date:  2019-09-06       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.